📣 VC round data is live. Check it out!

Goodwill Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Goodwill Pharma and similar public comparables like MediClin, Monash IVF Group, Clinica Las Condes, Athens Medical Centre and more.

Goodwill Pharma Overview

About Goodwill Pharma

Goodwill Pharma Nyrt is a full service pharma partner for the CEE region. The company s core activities include pharmaceutical logistics and distribution, pharmaceutical registration, full pharmaceutical marketing services, medical promotion, manufacturer and brand representation, own-licensed product development, manufacturing and marketing of proprietary pharmaceuticals and dietary supplements.


Founded

N/A

HQ

Hungary

Employees

N/A

Financials (FY)

Revenue: $75M
EBITDA: $20M

EV

$226M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Goodwill Pharma Financials

Goodwill Pharma reported last fiscal year revenue of $75M and EBITDA of $20M.

In the same fiscal year, Goodwill Pharma generated $32M in gross profit, $20M in EBITDA, and $8M in net income.


Goodwill Pharma P&L

In the most recent fiscal year, Goodwill Pharma reported revenue of $75M and EBITDA of $20M.

Goodwill Pharma is profitable as of last fiscal year, with gross margin of 43%, EBITDA margin of 27%, and net margin of 11%.

See analyst estimates for Goodwill Pharma
Last FY202320242025202620272028
Revenue$75M$52M$62M$75M
Gross Profit$32M$20M$20M$32M
Gross Margin43%37%33%43%
EBITDA$20M$8M$10M$20M
EBITDA Margin27%14%17%27%
EBIT Margin6%9%12%6%
Net Profit$8M$5M$6M$8M
Net Margin11%9%10%11%
Net Debt$14M---

Financial data powered by Morningstar, Inc.

Goodwill Pharma Stock Performance

Goodwill Pharma has current market cap of $209M, and enterprise value of $226M.

Market Cap Evolution


Goodwill Pharma's stock price is $1.95.

Goodwill Pharma share price increased by 5.3% in the last 30 days.

Goodwill Pharma has an EPS (earnings per share) of $0.08.

See more trading valuation data for Goodwill Pharma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$226M$209M5.3%5.3%3.0%-$0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Goodwill Pharma Valuation Multiples

Goodwill Pharma trades at 3.0x EV/Revenue multiple, and 11.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Goodwill Pharma

Goodwill Pharma Financial Valuation Multiples

As of June 2, 2026, Goodwill Pharma has market cap of $209M and EV of $226M.

Goodwill Pharma has a P/E ratio of 25.7x.

Last FY202320242025202620272028
EV/Revenue3.0x4.3x3.7x3.0x
EV/EBITDA11.2x29.9x21.9x11.2x
EV/EBIT52.2x45.9x30.4x52.2x
EV/Gross Profit7.0x11.5x11.2x7.0x
P/E25.7x44.4x32.4x25.7x
EV/FCF18.3x(22.7x)(22.7x)18.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Goodwill Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Goodwill Pharma Margins & Growth Rates

In the most recent fiscal year, Goodwill Pharma reported gross margin of 43%, EBITDA margin of 27%, and net margin of 11%.

See estimated margins and future growth rates for Goodwill Pharma

Goodwill Pharma Margins

Last FY20242025202720282029
Gross Margin43%33%43%
EBITDA Margin27%17%27%
EBIT Margin6%12%6%
Net Margin11%10%11%
FCF Margin16%(16%)16%

Goodwill Pharma Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth18%22%
Gross Profit Growth3%59%
EBITDA Growth37%94%
EBIT Growth51%(42%)
Net Profit Growth37%26%
FCF Growth0%(224%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Goodwill Pharma Operational KPIs

Access forward-looking KPIs for Goodwill Pharma
Last FY202320242025202620272028
S&M Expenses to Revenue5%--5%
G&A Expenses to Revenue2%--2%
R&D Expenses to Revenue0%--0%
Opex to Revenue37%28%21%37%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Goodwill Pharma Competitors

Goodwill Pharma competitors include MediClin, Monash IVF Group, Clinica Las Condes, Athens Medical Centre, Atrys Health, Limes Schlosskliniken, Suraksha Diagnostics, Hyperfine, Centrum Medyczne ENEL-MED and Humana.

Most Goodwill Pharma public comparables operate across Hospitals & Clinics.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
MediClin0.5x0.5x3.7x3.5x
Monash IVF Group1.7x1.8x7.4x8.0x
Clinica Las Condes2.7x-(5.9x)-
Athens Medical Centre1.1x-11.0x-
Atrys Health2.8x2.7x19.4x17.6x
Limes Schlosskliniken2.7x2.5x10.9x9.6x
Suraksha Diagnostics5.1x5.3x15.9x17.0x
Hyperfine9.1x7.6x(3.5x)(3.7x)

This data is available for Pro users. Sign up to see all Goodwill Pharma competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Goodwill Pharma

Where is Goodwill Pharma headquartered?Goodwill Pharma is headquartered in Hungary.
Is Goodwill Pharma publicly listed?Yes, Goodwill Pharma is a public company listed on Budapest Stock Exchange.
What is the stock symbol of Goodwill Pharma?Goodwill Pharma trades under GOODWILLPHRM ticker.
When did Goodwill Pharma go public?Goodwill Pharma went public in 2022.
Who are competitors of Goodwill Pharma?Goodwill Pharma main competitors include MediClin, Monash IVF Group, Clinica Las Condes, Athens Medical Centre, Atrys Health, Limes Schlosskliniken, Suraksha Diagnostics, Hyperfine, Centrum Medyczne ENEL-MED, Humana.
What is the current market cap of Goodwill Pharma?Goodwill Pharma's current market cap is $209M.
What is the current revenue of Goodwill Pharma?Goodwill Pharma's last fiscal year revenue is $75M.
What is the current EV/Revenue multiple of Goodwill Pharma?Current revenue multiple of Goodwill Pharma is 3.0x.
Is Goodwill Pharma profitable?No, Goodwill Pharma is not profitable.
How many companies Goodwill Pharma has acquired to date?Goodwill Pharma hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Goodwill Pharma has invested to date?Goodwill Pharma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Goodwill Pharma

Lists including Goodwill Pharma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial